Subcutaneous Lavage in Cesarean Section
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Subcutaneous washing, no subcutaneous washing.
- Who it may be relevant to
- Registry conditions: Surgical Site Infection. Basic parameters: No limits · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Israel
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Antiseptic Washing Prior to Skin Closure During Cesarean Delivery- a Randomized Control Trial
Overview
The goal of this clinical trial is to learn if antiseptic washing prior to skin closure during cesarean section reduces rates of surgical site infection. intraoperative washing is a common practice in other surgical fields and several studies have shown efficacy in reducing postoperative infection rates. no randomized control trial has tested this intervention during cesarean section. The main questions we aim to answer are: Does subcutaneous antiseptic washing reduce the rates of surgical site infection? Does antiseptic washing improve scar healing? Does antiseptic washing reduce hospital stay, postpartum fever rates and readmission cases? Researchers will compare subcutaneous antiseptic washing to no intervention to see if surgical site infection rates reduce Participants will: consent to participate in the trial Visit the postpartum clinic 30 days after surgery
Interventions
- Procedure Subcutaneous washing
subcutaneous washing with chlorhexidine gluconate prior to skin closure - Procedure no subcutaneous washing
no washing
Primary outcome measures
- surgical site infection [Time frame: 30 days after surgery]
Secondary outcome measures (3)
- hospital stay [Time frame: 30 days after surgery]
- wound healing [Time frame: 30 days after surgery]
- postpartum fever [Time frame: 30 days after surgery]
Eligibility criteria
Inclusion criteria
- pregnant women undergoing cesarean delivery
Exclusion criteria
- pregnant women undergoing vaginal delivery
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Israel · 1 center
- Hadassah Medical Organization — Jerusalem
Identifiers
NCT: NCT06454227 · WASHCD-HMO-CTIL